Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
CIK #0000078003
SectorLife Sciences
IndustryPharmaceutical Preparations
Address235 E 42Nd St
New York, NY 10017
Source [EDGAR]
Market Cap, 13F ($BB)

Pfizer Inc. is a research-based, global biopharmaceutical company. We apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture and distribution of healthcare products, including innovative medicines and vaccines. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Our revenues are derived from the sale of our products and, to a much lesser extent, from alliance agreements, under which we co-promote products discovered or developed by other companies or us. The majority of our revenues come from the manufacture and sale of biopharmaceutical products. The Company was incorporated under the laws of the State of Delaware on June 2, 1942.

We believe that our medicines provide significant value for both healthcare providers and patients, not only from the improved treatment of diseases but also from a reduction in other healthcare costs, such as emergency room or hospitalization costs, as well as improvements in health, wellness and productivity. We continue to actively engage in dialogues about the value of our medicines and how we can best work with patients, physicians and payers to prevent and treat disease and improve outcomes. We continue to work within the current legal and pricing structures, as well as continue to review our pricing arrangements and contracting methods with payers, to maximize patient access and minimize any adverse impact on our revenues. We remain firmly committed to fulfilling our Company's purpose: Breakthroughs that change patients' lives. By doing so, we expect to create value for the patients we serve and for our colleagues and shareholders.

With the formation of the GSK Consumer Healthcare joint venture and the pending combination of Upjohn with Mylan, which are further discussed below, Pfizer is transforming itself into a more focused, global leader in science-based innovative medicines.

CIK Filing 2011 - 2021
[0000078003] 10-K
[0000078003] 10-Q
[0000078003] 3
[0000078003] 4
[0000078003] 5
[0000078003] 8-K
[0000078003] SC 13D
[0000078003] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Pfizer Inc Homology Medicines Inc [2020-11-19] 0.9
Pfizer Inc Cerevel Therapeutics Holdings Inc [2020-11-06] 21.5
Pfizer Inc ESSA Pharma Inc [2020-08-06] 6.0
Pfizer Inc Imara Inc [2020-03-26] 0.4
Pfizer Inc Morphic Holding Inc [2020-02-14] 8.3
Pfizer Inc Springworks Therapeutics Inc [2020-02-14] 10.7
State Street Corp Pfizer Inc [2020-02-13] 5.28
Pfizer Inc Contrafect Corp [2019-12-16] 8.7
Pfizer Inc Cortexyme Inc [2019-05-22] 12.2
Pfizer Inc Nextcure Inc [2019-05-22] 8.7
State Street Corp Pfizer Inc [2019-02-14] 5.1
Pfizer Inc Allogene Therapeutics Inc [2018-10-22] 18.7
State Street Corp Pfizer Inc [2018-02-14] 5.25
Pfizer Inc Rhythm Pharmaceuticals Inc [2017-10-18] 9.0
Pfizer Inc Mersana Therapeutics Inc [2017-07-13] 9.0
Pfizer Inc Gemphire Therapeutics Inc [2017-02-13] 9.0
Pfizer Inc ICU Medical Inc/De [2017-02-13] 16.4
State Street Corp Pfizer Inc [2017-02-08] 5.31
Pfizer Inc Merus NV [2016-06-06] 7.1
Pfizer Inc Wave Life Sciences Ltd [2016-05-12] 9.0
State Street Corp Pfizer Inc [2016-02-16] 5.1
Pfizer Inc Cellectis SA [2016-02-16] 9.0
Pfizer Inc Protalix Biotherapeutics Inc [2015-10-23] 9.0
Pfizer Inc Cytomx Therapeutics Inc [2015-10-21] 9.0
Pfizer Inc Mirna Therapeutics Inc [2015-10-14] 9.0
Vanguard Group Inc Pfizer Inc [2015-02-11] 5.45
Pfizer Inc Flexion Therapeutics Inc [2015-02-05] 7.9
Pfizer Inc Aquinox Pharmaceuticals Inc [2014-03-21] 9.0
Pfizer Inc Celladon Corp [2014-02-14] 9.0
Pfizer Inc Tetralogic Pharmaceuticals Corp [2014-02-13] 9.0
Pfizer Inc Esperion Therapeutics Inc [2014-02-13] 9.0
Pfizer Inc Five Prime Therapeutics Inc [2013-09-27] 9.0
Pfizer Inc Clovis Oncology Inc [2012-03-09] 9.0
Form 3/4/5 Filer 2011-2021
Young John D
Bioatla Inc
Pfizer Ventures US LLC
Hwang Angela
Lankler Douglas M
Damico Jennifer B
Bourla Albert
Johnson RADY A
Upjohn Inc
Susman Sally
Cerevel Therapeutics Holdings Inc
Smith James C
Quincey James
Echevarria Joseph
Narayen Shantanu
Kilts James M
Blaylock Ronald E
Carapezzi William R Jr
Sahni Payal
Rogers Dawn
Cortexyme Inc
Pfizer Strategic Investment Holdings LLC
Dolsten Mikael
Littman Dan R
Hockfield Susan
Hobbs Helen
Gottlieb Scott
Cornwell W Don
Desmond-Hellmann Susan
NORA Johnson Suzanne M
Imara Inc
Cangialosi Loretta V
Damelio Frank A
Goettler Michael
Mackenzie Alexander R
Fonseca Lidia
Springworks Therapeutics Inc
Read Ian C
Lewis-Hall Freda C
Pfizer Production LLC
Pfizer Manufacturing LLC
CP Pharmaceuticals International CV
ICU Medical Inc/De
Allogene Therapeutics Inc